Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer

Keyphrases

• Head-and-neck Cancer 100%
• Xerostomia 100%
• Pilocarpine 100%
• Post-irradiation 100%
• Oral pilocarpine 100%
• Head-and-neck 80%
• Irradiation 60%
• Placebo Groups 60%
• Placebo 40%
• Radiation Therapy 40%
• Saliva 40%
• Adverse Effects 40%
• Sweating 40%
• Saliva Production 40%
• Randomized Placebo-controlled Trial 20%
• Prospective Randomized Trial 20%
• Fibrosis 20%
• Symptom Relief 20%
• Oral Infection 20%
• Salivary Gland 20%
• Increased Vulnerability 20%
• Common Complications 20%
• Tongue 20%
• Dental Caries 20%
• Hypofunction 20%
• Oral Pain 20%
• Serious Adverse Effects 20%
• Radiation-induced Xerostomia 20%
• Pilocarpine Hydrochloride 20%
• Cholinergic Effects 20%
• Speaking Ability 20%
• Oral Discomfort 20%
• Oral Dryness 20%

Medicine and Dentistry

• Head and Neck Cancer 100%
• Xerostomia 100%
• Pilocarpine 100%
• Oral 100%
• Placebo 85%
• Neck 57%
• Malignant Neoplasm 28%
• Radiation Therapy 28%
• Adverse Effect 28%
• Base 14%
• Mouth 14%
• Salivary Gland 14%
• Adverse Event 14%
• Mouth Infection 14%
• Fibrosis 14%
• Tongue 14%
• Parenchyma 14%
• Dental Caries 14%
• Mouth Pain 14%
• Mouth Discomfort 14%
• Side Effect 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Pilocarpine 100%
• Xerostomia 100%
• Head and Neck Cancer 100%
• Placebo 85%
• Malignant Neoplasm 28%
• Cholinergic Receptor Stimulating Agent 14%
• Adverse Event 14%
• Mouth Pain 14%
• Mouth Infection 14%
• Mouth Discomfort 14%
• Base 14%
• Fibrosis 14%
• Dental Caries 14%
• Side Effect 14%